Renovaro Biosciences Inc (NASDAQ:RENB)
| 3.85 Delayed Data As of Sep 22 |  0.00 / 0.00%Today’s Change | 0.39 Today|||52-Week Range 3.99 | +273.79% Year-to-Date |
Latest RENB News | Press Releases
No recent news for Renovaro Biosciences Inc.
Today’s Trading
| Previous close | 3.85 |
| Today’s open | 3.76 |
| Day’s range | 3.68 - 3.89 |
| Volume | 4,575 |
| Average volume (3 months) | 722,596 |
| Market cap | $225.0M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -281.13% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.82 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$113.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
